A recent study reveals that patients who come off blockbuster slimming jabs like semaglutide or tirzepatide may regain shed pounds at a significantly accelerated pace than those who stop conventional diet and exercise plans.
Published data in a leading health publication points out that while overweight individuals frequently drop about a fifth of their total mass while using the jabs, the weight returns at an estimated rate of 0.8 kg per month after stopping.
"Individuals purchasing these drugs need to be aware of the potential of fast weight regain when the treatment concludes," cautioned expert Dr. Susan Jebb.
That rate of recovery means a return to original weight in about 18 months.
Weighing Therapies
The analysis, which looked at 37 of trials involving thousands of patients, compared the effects of the injectable medications with conventional dieting.
The team note that individuals who shed pounds through diet and exercise typically have a more gradual weight regain—approximately 100 grams monthly—after stopping.
Explaining the Fast Rebound
Doctors suggest the mode of action of the drugs is key to understanding the amplified weight return.
These medications mimic a body's own chemical called GLP-1, which controls feelings of fullness.
"Long-term administration of the hormone levels several times higher than normal could lead to the body to generate a reduced amount of its endogenous hormone, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this hormone supplement leads to appetite is unsuppressed, making overeating a significant risk."
A Lifelong Disease?
The NHS recommend the jabs for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.
A number of clinicians contend that, considering the significant potential of relapse, the treatment should be considered life-long.
This opinion is supported by pharmaceutical companies, who state that the results "highlight the chronic character of obesity," akin to managing diseases like diabetes.
User Experiences
Users who have come off the jabs explain a intense resurgence of cravings.
"I experienced a switch activating and you're instantly starving," said one woman.
This difficulty is exacerbated if users have not adopted permanent dietary or behavioural changes during treatment.
Growing Interest
Survey data indicate that a significant number of people in the UK have tried these injections in the past year, with demand being substantial.
- Use is greater among women than males.
- The middle-aged age group shows the highest level of interest.
- Many obtain the drugs through private prescriptions rather than public health services.
In conclusion, clinicians emphasize that while these medications are effective tools for weight loss, they are not a standalone solution and lasting health benefits likely depends on integrated lifestyle management.